AEMD - Company ID 0000882291
The table below shows AETHLON MEDICAL INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $532.78K | $294.32K | $524.37K | $240.20K | $261.49K | $414.66K |
| SG&A |
AETHLON MEDICAL INC reported annual revenue of $0.00 for fiscal year 2024. That is down 100.0% from $574.25K in fiscal 2023. Over the 10 fiscal years shown, annual revenue declined from $762.42K (FY 2015) to $0.00. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $741.65K |
| $521.42K |
| $735.36K |
| $816.38K |
| $958.38K |
| $751.97K |
| Operating income | -$2.06M | -$1.51M | -$1.79M | -$1.81M | -$2.90M | -$2.62M |
| Income tax | - | - | - | - | - | - |
| Net income | -$2.02M | -$1.49M | -$1.76M | -$1.75M | -$2.81M | -$2.57M |
| EPS (diluted) | -$2.45 | -$3.74 | -$0.85 | -$10.05 | -$16.11 | -$2.76 |